Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura

Toshihiro Uchida, Hideo Wada, Minoru Mizutani, Miho Iwashita, Hiroaki Ishihara, Toshiro Shibano, Misako Suzuki, Yumiko Matsubara, Kenji Soejima, Masanori Matsumoto, Yoshihiro Fujimura, Yasuo Ikeda, Mitsuru Murata

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Congenital thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) is associated with an inherited von Willebrand factor-cleaving protease (ADAMTS13 [a disintegrin and metalloprotease with thrombospondin type I domains 13]) deficiency. In this study, we identified novel mutations in the ADAMTS13 gene in a patient with TTP. The patient was a 51-year-old Japanese male who exhibited TTP symptoms at frequent intervals. The ADAMTS13 activity during acute episodes was less than 3% that of normal. The enzyme activities of the patient's father and mother were both 46%, and both parents were asymptomatic. Genetic analysis revealed that the patient was a compound heterozygote for 2 mutations. One mutation was a missense mutation in the metalloprotease domain (A250V, exon 7), and the other was a guanine to adenine substitution at the 5′ end of intron 3 (intron 3 G→A). In vitro expression studies revealed that the A250V mutation markedly reduced ADAMTS13 activity and the intron 3 G→A mutation caused abnormal mRNA synthesis.

Original languageEnglish
Pages (from-to)2081-2083
Number of pages3
JournalBlood
Volume104
Issue number7
DOIs
Publication statusPublished - 2004 Oct 1

Fingerprint

Thrombotic Thrombocytopenic Purpura
Introns
Metalloproteases
Mutation
Thrombospondins
Disintegrins
Guanine
von Willebrand Factor
Enzyme activity
Adenine
Exons
Peptide Hydrolases
Substitution reactions
Genes
Hemolytic-Uremic Syndrome
Missense Mutation
Heterozygote
Messenger RNA
Fathers
Parents

ASJC Scopus subject areas

  • Hematology

Cite this

Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura. / Uchida, Toshihiro; Wada, Hideo; Mizutani, Minoru; Iwashita, Miho; Ishihara, Hiroaki; Shibano, Toshiro; Suzuki, Misako; Matsubara, Yumiko; Soejima, Kenji; Matsumoto, Masanori; Fujimura, Yoshihiro; Ikeda, Yasuo; Murata, Mitsuru.

In: Blood, Vol. 104, No. 7, 01.10.2004, p. 2081-2083.

Research output: Contribution to journalArticle

Uchida, T, Wada, H, Mizutani, M, Iwashita, M, Ishihara, H, Shibano, T, Suzuki, M, Matsubara, Y, Soejima, K, Matsumoto, M, Fujimura, Y, Ikeda, Y & Murata, M 2004, 'Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura', Blood, vol. 104, no. 7, pp. 2081-2083. https://doi.org/10.1182/blood-2004-02-0715
Uchida, Toshihiro ; Wada, Hideo ; Mizutani, Minoru ; Iwashita, Miho ; Ishihara, Hiroaki ; Shibano, Toshiro ; Suzuki, Misako ; Matsubara, Yumiko ; Soejima, Kenji ; Matsumoto, Masanori ; Fujimura, Yoshihiro ; Ikeda, Yasuo ; Murata, Mitsuru. / Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura. In: Blood. 2004 ; Vol. 104, No. 7. pp. 2081-2083.
@article{25339ecfb94542e6bc03e22972f7b679,
title = "Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura",
abstract = "Congenital thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) is associated with an inherited von Willebrand factor-cleaving protease (ADAMTS13 [a disintegrin and metalloprotease with thrombospondin type I domains 13]) deficiency. In this study, we identified novel mutations in the ADAMTS13 gene in a patient with TTP. The patient was a 51-year-old Japanese male who exhibited TTP symptoms at frequent intervals. The ADAMTS13 activity during acute episodes was less than 3{\%} that of normal. The enzyme activities of the patient's father and mother were both 46{\%}, and both parents were asymptomatic. Genetic analysis revealed that the patient was a compound heterozygote for 2 mutations. One mutation was a missense mutation in the metalloprotease domain (A250V, exon 7), and the other was a guanine to adenine substitution at the 5′ end of intron 3 (intron 3 G→A). In vitro expression studies revealed that the A250V mutation markedly reduced ADAMTS13 activity and the intron 3 G→A mutation caused abnormal mRNA synthesis.",
author = "Toshihiro Uchida and Hideo Wada and Minoru Mizutani and Miho Iwashita and Hiroaki Ishihara and Toshiro Shibano and Misako Suzuki and Yumiko Matsubara and Kenji Soejima and Masanori Matsumoto and Yoshihiro Fujimura and Yasuo Ikeda and Mitsuru Murata",
year = "2004",
month = "10",
day = "1",
doi = "10.1182/blood-2004-02-0715",
language = "English",
volume = "104",
pages = "2081--2083",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "7",

}

TY - JOUR

T1 - Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura

AU - Uchida, Toshihiro

AU - Wada, Hideo

AU - Mizutani, Minoru

AU - Iwashita, Miho

AU - Ishihara, Hiroaki

AU - Shibano, Toshiro

AU - Suzuki, Misako

AU - Matsubara, Yumiko

AU - Soejima, Kenji

AU - Matsumoto, Masanori

AU - Fujimura, Yoshihiro

AU - Ikeda, Yasuo

AU - Murata, Mitsuru

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Congenital thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) is associated with an inherited von Willebrand factor-cleaving protease (ADAMTS13 [a disintegrin and metalloprotease with thrombospondin type I domains 13]) deficiency. In this study, we identified novel mutations in the ADAMTS13 gene in a patient with TTP. The patient was a 51-year-old Japanese male who exhibited TTP symptoms at frequent intervals. The ADAMTS13 activity during acute episodes was less than 3% that of normal. The enzyme activities of the patient's father and mother were both 46%, and both parents were asymptomatic. Genetic analysis revealed that the patient was a compound heterozygote for 2 mutations. One mutation was a missense mutation in the metalloprotease domain (A250V, exon 7), and the other was a guanine to adenine substitution at the 5′ end of intron 3 (intron 3 G→A). In vitro expression studies revealed that the A250V mutation markedly reduced ADAMTS13 activity and the intron 3 G→A mutation caused abnormal mRNA synthesis.

AB - Congenital thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) is associated with an inherited von Willebrand factor-cleaving protease (ADAMTS13 [a disintegrin and metalloprotease with thrombospondin type I domains 13]) deficiency. In this study, we identified novel mutations in the ADAMTS13 gene in a patient with TTP. The patient was a 51-year-old Japanese male who exhibited TTP symptoms at frequent intervals. The ADAMTS13 activity during acute episodes was less than 3% that of normal. The enzyme activities of the patient's father and mother were both 46%, and both parents were asymptomatic. Genetic analysis revealed that the patient was a compound heterozygote for 2 mutations. One mutation was a missense mutation in the metalloprotease domain (A250V, exon 7), and the other was a guanine to adenine substitution at the 5′ end of intron 3 (intron 3 G→A). In vitro expression studies revealed that the A250V mutation markedly reduced ADAMTS13 activity and the intron 3 G→A mutation caused abnormal mRNA synthesis.

UR - http://www.scopus.com/inward/record.url?scp=4644271599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644271599&partnerID=8YFLogxK

U2 - 10.1182/blood-2004-02-0715

DO - 10.1182/blood-2004-02-0715

M3 - Article

C2 - 15126318

AN - SCOPUS:4644271599

VL - 104

SP - 2081

EP - 2083

JO - Blood

JF - Blood

SN - 0006-4971

IS - 7

ER -